Albert David Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 24, 2025, 1:03 am

Market Cap	479 Cr.
Current Price	839
High / Low	1,754/763
Stock P/E	27.9
Book Value	688
Dividend Yield	0.60 %
ROCE	6.48 %
ROE	4.44 %
Face Value	10.0
PEG Ratio	-5.67

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Albert David Ltd

Competitors of Albert David Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	148 Cr.	105	247/84.3	28.7	41.7	0.00 %	12.9 %	9.75 %	10.0
MPS Pharmaa Ltd	5.49 Cr.	2.87	4.33/2.50		0.57	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	40.8 Cr.	55.0	94.9/44.5		8.73	0.00 %	41.5 %	14.4 %	10.0
Gujarat Inject (Kerala) Ltd	38.5 Cr.	26.3	29.1/13.1	37.8	6.83	0.00 %	13.5 %	11.0 %	10.0
Industry Average	18,521.40 Cr	1,148.22		93.91	194.82	0.31%	16.66%	15.19%	6.18

All Competitor Stocks of Albert David Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	74	93	92	75	81	92	93	88	89	89	98	83	75
Expenses	64	81	78	66	72	79	77	80	79	88	92	82	80
Operating Profit	10	12	14	8	10	13	16	8	10	1	6	1	-5
OPM %	13%	13%	15%	11%	12%	14%	17%	9%	11%	1%	6%	1%	-6%
Other Income	-1	-6	14	7	0	18	12	17	10	23	21	-9	-5
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	2	2	2	2	1	2	2	2	2	2	2
Profit before tax	7	4	26	14	7	29	27	23	18	22	25	-10	-12
Tax %	38%	60%	21%	22%	48%	20%	24%	20%	29%	15%	28%	-8%	-13%
Net Profit	4	2	20	11	4	23	20	19	13	19	18	-9	-10
EPS in Rs	7.31	3.08	35.29	18.49	6.54	41.16	35.57	32.80	22.62	33.01	31.66	-16.45	-18.10

Last Updated: May 31, 2025, 9:53 am

Below is a detailed analysis of the quarterly data for Albert David Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 75.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Dec 2024) to 75.00 Cr., marking a decrease of 8.00 Cr..
For Expenses, as of Mar 2025, the value is 80.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.00 Cr. (Dec 2024) to 80.00 Cr., marking a decrease of 2.00 Cr..
For Operating Profit, as of Mar 2025, the value is -5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Dec 2024) to -5.00 Cr., marking a decrease of 6.00 Cr..
For OPM %, as of Mar 2025, the value is -6.00%. The value appears to be declining and may need further review. It has decreased from 1.00% (Dec 2024) to -6.00%, marking a decrease of 7.00%.
For Other Income, as of Mar 2025, the value is -5.00 Cr.. The value appears strong and on an upward trend. It has increased from -9.00 Cr. (Dec 2024) to -5.00 Cr., marking an increase of 4.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
For Profit before tax, as of Mar 2025, the value is -12.00 Cr.. The value appears to be declining and may need further review. It has decreased from -10.00 Cr. (Dec 2024) to -12.00 Cr., marking a decrease of 2.00 Cr..
For Tax %, as of Mar 2025, the value is -13.00%. The value appears to be improving (decreasing) as expected. It has decreased from -8.00% (Dec 2024) to -13.00%, marking a decrease of 5.00%.
For Net Profit, as of Mar 2025, the value is -10.00 Cr.. The value appears to be declining and may need further review. It has decreased from -9.00 Cr. (Dec 2024) to -10.00 Cr., marking a decrease of 1.00 Cr..
For EPS in Rs, as of Mar 2025, the value is -18.10. The value appears to be declining and may need further review. It has decreased from -16.45 (Dec 2024) to -18.10, marking a decrease of 1.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:20 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	287	317	318	293	285	316	320	246	313	341	362	346
Expenses	254	281	286	266	267	286	289	227	272	297	315	343
Operating Profit	33	37	31	27	18	30	30	19	41	44	47	3
OPM %	11%	12%	10%	9%	6%	10%	10%	8%	13%	13%	13%	1%
Other Income	1	2	43	8	9	15	7	17	16	15	58	30
Interest	4	3	2	1	1	1	1	1	1	1	0	0
Depreciation	11	15	9	8	8	7	8	8	9	9	7	7
Profit before tax	18	20	63	26	18	38	29	27	47	51	97	25
Tax %	32%	32%	24%	39%	45%	29%	34%	19%	25%	29%	22%	32%
Net Profit	13	14	48	16	10	27	19	22	35	36	75	17
EPS in Rs	22.02	24.00	84.10	27.96	17.24	46.68	33.59	38.79	61.78	63.38	132.15	30.14
Dividend Payout %	23%	23%	7%	20%	32%	13%	21%	15%	15%	14%	9%	17%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	7.69%	242.86%	-66.67%	-37.50%	170.00%	-29.63%	15.79%	59.09%	2.86%	108.33%	-77.33%
Change in YoY Net Profit Growth (%)	0.00%	235.16%	-309.52%	29.17%	207.50%	-199.63%	45.42%	43.30%	-56.23%	105.48%	-185.67%

Albert David Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	1%
5 Years:	2%
3 Years:	3%
TTM:	-4%

Compounded Profit Growth
10 Years:	2%
5 Years:	-2%
3 Years:	-20%
TTM:	-77%

Stock Price CAGR
10 Years:	11%
5 Years:	12%
3 Years:	16%
1 Year:	-38%

Return on Equity
10 Years:	11%
5 Years:	12%
3 Years:	13%
Last Year:	4%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:31 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6	6	6	6	6	6	6	6	6	6	6	6
Reserves	85	87	131	177	180	205	217	239	274	306	377	387
Borrowings	42	30	20	30	28	0	2	2	6	5	3	12
Other Liabilities	66	71	67	71	76	84	95	95	116	106	112	107
Total Liabilities	198	193	224	285	290	295	320	341	401	423	498	511
Fixed Assets	67	49	44	87	83	77	91	84	88	80	83	99
CWIP	3	5	5	9	5	5	2	1	1	3	7	2
Investments	16	16	48	59	68	113	122	138	183	193	273	260
Other Assets	111	122	127	130	134	99	106	119	130	148	135	151
Total Assets	198	193	224	285	290	295	320	341	401	423	498	511

Below is a detailed analysis of the balance sheet data for Albert David Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
For Reserves, as of Mar 2025, the value is 387.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 387.00 Cr., marking an increase of 10.00 Cr..
For Borrowings, as of Mar 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 9.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 107.00 Cr.. The value appears to be improving (decreasing). It has decreased from 112.00 Cr. (Mar 2024) to 107.00 Cr., marking a decrease of 5.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 498.00 Cr. (Mar 2024) to 511.00 Cr., marking an increase of 13.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 16.00 Cr..
For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
For Investments, as of Mar 2025, the value is 260.00 Cr.. The value appears to be declining and may need further review. It has decreased from 273.00 Cr. (Mar 2024) to 260.00 Cr., marking a decrease of 13.00 Cr..
For Other Assets, as of Mar 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2024) to 151.00 Cr., marking an increase of 16.00 Cr..
For Total Assets, as of Mar 2025, the value is 511.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Mar 2024) to 511.00 Cr., marking an increase of 13.00 Cr..

Notably, the Reserves (387.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	21	28	68	20	30	32	30	37	40	11	46	-28
Cash from Investing Activity +	-24	-9	-38	-36	-11	-19	-20	-37	-40	-5	-33	23
Cash from Financing Activity +	-2	-18	-18	7	-5	-17	-10	-2	-2	-6	-8	0
Net Cash Flow	-5	1	12	-10	15	-4	0	-2	-1	-1	4	-5

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-9.00	7.00	11.00	-3.00	-10.00	30.00	28.00	17.00	35.00	39.00	44.00	-9.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	52	54	47	41	41	35	25	34	29	29	32	30
Inventory Days	165	191	176	187	217	173	151	148	151	124	149	126
Days Payable	110	135	103	102	117	127	102	132	104	96	95	98
Cash Conversion Cycle	107	111	120	126	141	81	74	50	76	57	87	58
Working Capital Days	61	57	52	48	61	45	22	18	-8	-29	19	-10
ROCE %	14%	18%	18%	17%	15%	7%	18%	14%	12%	17%	17%	28%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	61.96%	61.99%	61.99%	61.99%	62.04%	62.04%	62.04%	62.04%	62.13%	62.13%	62.13%	62.13%
FIIs	0.75%	0.64%	0.61%	0.57%	0.57%	0.65%	0.57%	0.70%	0.98%	0.80%	0.88%	0.86%
DIIs	3.18%	3.17%	2.97%	2.84%	2.80%	2.30%	1.90%	1.67%	1.67%	1.67%	1.63%	1.63%
Public	34.11%	34.19%	34.43%	34.60%	34.59%	35.01%	35.49%	35.60%	35.23%	35.41%	35.36%	35.39%
No. of Shareholders	10,645	10,708	10,381	10,010	9,786	9,828	9,907	10,041	11,266	12,349	13,590	14,830

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	132.15	63.39	61.78	38.80	33.59
Diluted EPS (Rs.)	132.15	63.39	61.78	38.80	33.59
Cash EPS (Rs.)	144.11	78.36	77.21	53.22	47.03
Book Value[Excl.RevalReserv]/Share (Rs.)	671.05	545.93	489.68	428.20	390.38
Book Value[Incl.RevalReserv]/Share (Rs.)	671.05	545.93	489.68	428.20	390.38
Dividend / Share (Rs.)	11.50	9.00	9.00	6.00	7.00
Revenue From Operations / Share (Rs.)	635.10	598.48	549.33	433.57	562.09
PBDIT / Share (Rs.)	182.98	104.67	99.23	63.65	65.58
PBIT / Share (Rs.)	171.02	89.69	83.81	49.23	52.13
PBT / Share (Rs.)	170.46	88.90	82.87	48.09	50.73
Net Profit / Share (Rs.)	132.15	63.38	61.78	38.80	33.59
PBDIT Margin (%)	28.81	17.49	18.06	14.68	11.66
PBIT Margin (%)	26.92	14.98	15.25	11.35	9.27
PBT Margin (%)	26.84	14.85	15.08	11.09	9.02
Net Profit Margin (%)	20.80	10.59	11.24	8.94	5.97
Return on Networth / Equity (%)	19.69	11.61	12.61	9.06	8.60
Return on Capital Employeed (%)	24.46	15.77	16.27	10.77	12.43
Return On Assets (%)	15.14	8.54	8.75	6.48	5.98
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.00	0.01
Total Debt / Equity (X)	0.01	0.01	0.01	0.00	0.01
Asset Turnover Ratio (%)	0.78	0.82	0.84	0.74	1.04
Current Ratio (X)	3.75	3.07	2.33	2.77	2.48
Quick Ratio (X)	3.31	2.55	1.97	2.33	1.95
Inventory Turnover Ratio (X)	1.36	1.41	1.37	0.93	1.29
Dividend Payout Ratio (NP) (%)	6.81	14.19	9.71	0.00	46.66
Dividend Payout Ratio (CP) (%)	6.24	11.48	7.77	0.00	33.32
Earning Retention Ratio (%)	93.19	85.81	90.29	0.00	53.34
Cash Earning Retention Ratio (%)	93.76	88.52	92.23	0.00	66.68
Interest Coverage Ratio (X)	325.13	131.04	106.40	55.62	47.01
Interest Coverage Ratio (Post Tax) (X)	235.81	80.35	67.24	34.90	25.08
Enterprise Value (Cr.)	584.89	270.90	288.62	180.08	178.32
EV / Net Operating Revenue (X)	1.61	0.79	0.92	0.72	0.55
EV / EBITDA (X)	5.60	4.53	5.10	4.96	4.76
MarketCap / Net Operating Revenue (X)	1.69	0.85	0.96	0.86	0.57
Retention Ratios (%)	93.18	85.80	90.28	0.00	53.33
Price / BV (X)	1.60	0.93	1.09	0.87	0.82
Price / Net Operating Revenue (X)	1.69	0.85	0.96	0.86	0.57
EarningsYield	0.12	0.12	0.11	0.10	0.10

After reviewing the key financial ratios for Albert David Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 132.15. This value is within the healthy range. It has increased from 63.39 (Mar 23) to 132.15, marking an increase of 68.76.
For Diluted EPS (Rs.), as of Mar 24, the value is 132.15. This value is within the healthy range. It has increased from 63.39 (Mar 23) to 132.15, marking an increase of 68.76.
For Cash EPS (Rs.), as of Mar 24, the value is 144.11. This value is within the healthy range. It has increased from 78.36 (Mar 23) to 144.11, marking an increase of 65.75.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 671.05. It has increased from 545.93 (Mar 23) to 671.05, marking an increase of 125.12.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 671.05. It has increased from 545.93 (Mar 23) to 671.05, marking an increase of 125.12.
For Dividend / Share (Rs.), as of Mar 24, the value is 11.50. This value exceeds the healthy maximum of 3. It has increased from 9.00 (Mar 23) to 11.50, marking an increase of 2.50.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 635.10. It has increased from 598.48 (Mar 23) to 635.10, marking an increase of 36.62.
For PBDIT / Share (Rs.), as of Mar 24, the value is 182.98. This value is within the healthy range. It has increased from 104.67 (Mar 23) to 182.98, marking an increase of 78.31.
For PBIT / Share (Rs.), as of Mar 24, the value is 171.02. This value is within the healthy range. It has increased from 89.69 (Mar 23) to 171.02, marking an increase of 81.33.
For PBT / Share (Rs.), as of Mar 24, the value is 170.46. This value is within the healthy range. It has increased from 88.90 (Mar 23) to 170.46, marking an increase of 81.56.
For Net Profit / Share (Rs.), as of Mar 24, the value is 132.15. This value is within the healthy range. It has increased from 63.38 (Mar 23) to 132.15, marking an increase of 68.77.
For PBDIT Margin (%), as of Mar 24, the value is 28.81. This value is within the healthy range. It has increased from 17.49 (Mar 23) to 28.81, marking an increase of 11.32.
For PBIT Margin (%), as of Mar 24, the value is 26.92. This value exceeds the healthy maximum of 20. It has increased from 14.98 (Mar 23) to 26.92, marking an increase of 11.94.
For PBT Margin (%), as of Mar 24, the value is 26.84. This value is within the healthy range. It has increased from 14.85 (Mar 23) to 26.84, marking an increase of 11.99.
For Net Profit Margin (%), as of Mar 24, the value is 20.80. This value exceeds the healthy maximum of 10. It has increased from 10.59 (Mar 23) to 20.80, marking an increase of 10.21.
For Return on Networth / Equity (%), as of Mar 24, the value is 19.69. This value is within the healthy range. It has increased from 11.61 (Mar 23) to 19.69, marking an increase of 8.08.
For Return on Capital Employeed (%), as of Mar 24, the value is 24.46. This value is within the healthy range. It has increased from 15.77 (Mar 23) to 24.46, marking an increase of 8.69.
For Return On Assets (%), as of Mar 24, the value is 15.14. This value is within the healthy range. It has increased from 8.54 (Mar 23) to 15.14, marking an increase of 6.60.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.78. It has decreased from 0.82 (Mar 23) to 0.78, marking a decrease of 0.04.
For Current Ratio (X), as of Mar 24, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 3.07 (Mar 23) to 3.75, marking an increase of 0.68.
For Quick Ratio (X), as of Mar 24, the value is 3.31. This value exceeds the healthy maximum of 2. It has increased from 2.55 (Mar 23) to 3.31, marking an increase of 0.76.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.36. This value is below the healthy minimum of 4. It has decreased from 1.41 (Mar 23) to 1.36, marking a decrease of 0.05.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.81. This value is below the healthy minimum of 20. It has decreased from 14.19 (Mar 23) to 6.81, marking a decrease of 7.38.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.24. This value is below the healthy minimum of 20. It has decreased from 11.48 (Mar 23) to 6.24, marking a decrease of 5.24.
For Earning Retention Ratio (%), as of Mar 24, the value is 93.19. This value exceeds the healthy maximum of 70. It has increased from 85.81 (Mar 23) to 93.19, marking an increase of 7.38.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.76. This value exceeds the healthy maximum of 70. It has increased from 88.52 (Mar 23) to 93.76, marking an increase of 5.24.
For Interest Coverage Ratio (X), as of Mar 24, the value is 325.13. This value is within the healthy range. It has increased from 131.04 (Mar 23) to 325.13, marking an increase of 194.09.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 235.81. This value is within the healthy range. It has increased from 80.35 (Mar 23) to 235.81, marking an increase of 155.46.
For Enterprise Value (Cr.), as of Mar 24, the value is 584.89. It has increased from 270.90 (Mar 23) to 584.89, marking an increase of 313.99.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has increased from 0.79 (Mar 23) to 1.61, marking an increase of 0.82.
For EV / EBITDA (X), as of Mar 24, the value is 5.60. This value is within the healthy range. It has increased from 4.53 (Mar 23) to 5.60, marking an increase of 1.07.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 0.85 (Mar 23) to 1.69, marking an increase of 0.84.
For Retention Ratios (%), as of Mar 24, the value is 93.18. This value exceeds the healthy maximum of 70. It has increased from 85.80 (Mar 23) to 93.18, marking an increase of 7.38.
For Price / BV (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 0.93 (Mar 23) to 1.60, marking an increase of 0.67.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 0.85 (Mar 23) to 1.69, marking an increase of 0.84.
For EarningsYield, as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Albert David Ltd as of June 24, 2025 is: 685.90

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 24, 2025, Albert David Ltd is Overvalued by 18.25% compared to the current share price 839.00

Intrinsic Value of Albert David Ltd as of June 24, 2025 is: 652.15

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 24, 2025, Albert David Ltd is Overvalued by 22.27% compared to the current share price 839.00

Last 5 Year EPS CAGR: -4.92%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 16.25%, which is a positive sign. The stock has a low average Working Capital Days of 28.00, which is a positive sign. The company has higher reserves (222.08 cr) compared to borrowings (15.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (312.00 cr) and profit (38.25 cr) over the years.	The stock has a high average Cash Conversion Cycle of 90.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Albert David Ltd:
1. Net Profit Margin: 20.8%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 24.46% (Industry Average ROCE: 16.66%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 19.69% (Industry Average ROE: 15.19%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 235.81
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3.31
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 27.9 (Industry average Stock P/E: 93.91)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Albert David Ltd. is a Public Limited Listed company incorporated on 16/11/1938 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L51109WB1938PLC009490 and registration number is 009490. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 345.77 Cr. and Equity Capital is Rs. 5.71 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	D - Block, 3rd Floor, Gillander House, Kolkata West Bengal 700001	adidavid@dataone.in http://www.albertdavidindia.com

Management
Name	Position Held
Mr. Arun Kumar Kothari	Executive Chairman
Mr. Umesh Manohar Kunte	Managing Director & CEO
Mrs. Prabhawati Devi Kothari	Non Executive Director
Mr. Anand Vardhan Kothari	Non Executive Director
Mr. Anurag Singhi	Ind. Non-Executive Director
Mr. Shourya Sengupta	Ind. Non-Executive Director
Mr. Shirish G Belapure	Ind. Non-Executive Director
Dr. Monjori Mitra	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Albert David Ltd?

Albert David Ltd's intrinsic value (as of 24 June 2025) is ₹685.90 — 18.25% lower the current market price of 839.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 479 Cr. market cap, FY2025-2026 high/low of ₹1,754/763, reserves of 387 Cr, and liabilities of 511 Cr.

What is the Market Cap of Albert David Ltd?

The Market Cap of Albert David Ltd is 479 Cr..

What is the current Stock Price of Albert David Ltd as on 24 June 2025?

The current stock price of Albert David Ltd as on 24 June 2025 is 839.

What is the High / Low of Albert David Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Albert David Ltd stocks is ₹1,754/763.

What is the Stock P/E of Albert David Ltd?

The Stock P/E of Albert David Ltd is 27.9.

What is the Book Value of Albert David Ltd?

The Book Value of Albert David Ltd is 688.

What is the Dividend Yield of Albert David Ltd?

The Dividend Yield of Albert David Ltd is 0.60 %.

What is the ROCE of Albert David Ltd?

The ROCE of Albert David Ltd is 6.48 %.

What is the ROE of Albert David Ltd?

The ROE of Albert David Ltd is 4.44 %.

What is the Face Value of Albert David Ltd?

The Face Value of Albert David Ltd is 10.0.